Faculty profile

Swapnil Hiremath

ResearcherNephrologyUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses may be missing. Find their university profile.

Swapnil Hiremath

Researcher

Nephrology

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
67 publications in the last five years, latest in 2026.
Senior (last) author on 24 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

226

Publications

4,064

Citations

133

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Personal Website Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Acute Kidney Injury Contrast Media Drug Discontinuation Systematic Review

Latest papers

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review
Canadian Journal of Kidney Health and Disease · 2026
Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways.
American journal of hypertension · 2026
Cardiovascular and Kidney Outcomes of Living Kidney Donors With Preexisting Hypertension: A Systematic Review and Meta-Analysis.
American journal of hypertension · 2026

All 226 publications

Latest funding

Satisfaction in Hemodialysis Patients On ShoWERing With CVCs and Healed Exit Sites: the SHOWER study
CIHR · 2026 · Co-investigator
$711,451
Pragmatic randomized trial of High Or Standard PHosphAte Targets in End-stage kidney disease (PHOSPHATE)
CIHR · 2024 · Co-investigator
$1,526,176
A prospective interventional study to prevent allosensitization in patients who have failed a first kidney transplant
CIHR · 2024 · Co-investigator
$539,326

All 13 grants and awards

From the 150 most recent of 226 publications.

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review

Tannar B, Al-Hellawi H, Sontrop JM, Acedillo RR, Al-Jaishi AA, Anderson S, Bagga A, Berry D, Beaubien E, Blake PG

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261454463

Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways.

Sriperumbuduri S, Khan RW, Aftab S, Hiremath S, Dixon D, Gupta G

American journal of hypertension2026

DOI: 10.1093/ajh/hpag111 PMID: 42712144

Cardiovascular and Kidney Outcomes of Living Kidney Donors With Preexisting Hypertension: A Systematic Review and Meta-Analysis.

Eldaba M, Ahmed S, Hiremath S, Shorr R, Clark EG, Burns KD, Knoll G, Bugeja A

American journal of hypertension2026

DOI: 10.1093/ajh/hpaf114 PMID: 40570153

Salty Science: The Promise of Proteomics to Unravel Cardiovascular Consequences.

Hiremath S

American journal of hypertension2026First author

DOI: 10.1093/ajh/hpaf185 PMID: 40971683

Arterial hypertension-attributable mortality in Europe: implications for the Americas.

Zanuzzi MG, Hiremath S, Romero CA, Wynne BM

Journal of hypertension2026

DOI: 10.1097/hjh.0000000000004190 PMID: 41342426

Management of hypertension in chronic kidney disease.

Doulton T, Swift PA, Hiremath S

Clinical medicine (London, England)2026Senior author

DOI: 10.1016/j.clinme.2026.100583 PMID: 42035931

Comparing Catheters with Fistulas in Older Patients Starting Hemodialysis: A Pilot Randomized Controlled Trial.

Quinn RR, Oliver MJ, Wald R, Hiremath S, Pauly RP, Miller L, Barrett B, Nesrallah G, Gallagher M, Kotwal S, Gray NA, Hassan HC, Talaulikar GS, Thorpe K, Graham J, Clarke A, Bian J, MacRae J, Santana M, Bohm C, Mamdani M, Nagpal S, Yilmaz S, Moist L, Ravani P

Journal of the American Society of Nephrology : JASN2026

DOI: 10.1681/asn.0000001160 PMID: 42319856

Cuffless blood pressure in 2025: from promise to practice: a narrative review.

Wehbe F, Hiremath S

Current opinion in nephrology and hypertension2026Senior author

DOI: 10.1097/mnh.0000000000001150 PMID: 41460057

Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial

Killin L, Bohm C, Harris C, MacRae JM, Shah N, Thompson S, Tonelli M, Luo B, Sontrop JM, Acedillo RR

Canadian Journal of Kidney Health and Disease20251 citations

DOI: 10.1177/20543581251385011

Risk Factors for Suboptimal Dialysis Initiation

Molnar AO, Brimble KS, Bota SE, Kang Y, Harmon JP, Hiremath S, Brown PA, Silver SA, Akbari A

Kidney36020251 citations

DOI: 10.34067/kid.0000000895

Something wrong or missing on this profile? Suggest a correction

Swapnil Hiremath

Research

Latest papers

Latest funding

Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative Review

Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways.

Cardiovascular and Kidney Outcomes of Living Kidney Donors With Preexisting Hypertension: A Systematic Review and Meta-Analysis.

Salty Science: The Promise of Proteomics to Unravel Cardiovascular Consequences.

Arterial hypertension-attributable mortality in Europe: implications for the Americas.

Management of hypertension in chronic kidney disease.

Comparing Catheters with Fistulas in Older Patients Starting Hemodialysis: A Pilot Randomized Controlled Trial.

Cuffless blood pressure in 2025: from promise to practice: a narrative review.

Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial

Risk Factors for Suboptimal Dialysis Initiation

Frequent collaborators

Marcel Ruzicka

Ayub Akbari

Ron Wald

Edward Clark

Amit Garg

Cedric Edwards

Pietro Ravani

Amber Molnar

Deborah Zimmerman

Louise Moist

Salmaan Kanji

Brendan McCormick

Wael Shabana

Christopher McCudden

Andrew Pipe

Jennifer Macrae

Richard Lewanczuk

Charlotte Jones

Charmaine Lok

Lauralyn McIntyre

Steven Grover

Navdeep Tangri

Dean Fergusson

Peter Selby

Mukul Sharma

Ally Prebtani

Paul Oh

Kaberi Dasgupta

Kaberi Dasgupta

Meranda Nakhla

Kerri-Anne Mullen

Meranda Nakhla

Clara Bohm

Matthew James

Scott Brimble

Marcello Tonelli

Sonia Butalia

Kerry McBrien

Sanjay Pandeya

Kathleen Quinn